443 related articles for article (PubMed ID: 15644488)
1. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).
Bouley R; Pastor-Soler N; Cohen O; McLaughlin M; Breton S; Brown D
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1103-12. PubMed ID: 15644488
[TBL] [Abstract][Full Text] [Related]
2. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
Boone M; Kortenoeven M; Robben JH; Deen PM
Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
[TBL] [Abstract][Full Text] [Related]
3. Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney.
Russo LM; McKee M; Brown D
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F246-53. PubMed ID: 16449354
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells.
Bouley R; Breton S; Sun T; McLaughlin M; Nsumu NN; Lin HY; Ausiello DA; Brown D
J Clin Invest; 2000 Nov; 106(9):1115-26. PubMed ID: 11067864
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil treatment in vivo stimulates Leydig cell steroidogenesis via the cAMP/cGMP signaling pathway.
Andric SA; Janjic MM; Stojkov NJ; Kostic TS
Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E544-50. PubMed ID: 20663985
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil.
Zhu CB; Hewlett WA; Francis SH; Corbin JD; Blakely RD
Eur J Pharmacol; 2004 Nov; 504(1-2):1-6. PubMed ID: 15507214
[TBL] [Abstract][Full Text] [Related]
7. Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.
Pauvert O; Lugnier C; Keravis T; Marthan R; Rousseau E; Savineau JP
Br J Pharmacol; 2003 Jun; 139(3):513-22. PubMed ID: 12788811
[TBL] [Abstract][Full Text] [Related]
8. The cGMP-binding, cGMP-specific phosphodiesterase (PDE5): intestinal cell expression, regulation and role in fluid secretion.
Sopory S; Kaur T; Visweswariah SS
Cell Signal; 2004 Jun; 16(6):681-92. PubMed ID: 15093609
[TBL] [Abstract][Full Text] [Related]
9. [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP.
Corbin JD; Blount MA; Weeks JL; Beasley A; Kuhn KP; Ho YS; Saidi LF; Hurley JH; Kotera J; Francis SH
Mol Pharmacol; 2003 Jun; 63(6):1364-72. PubMed ID: 12761347
[TBL] [Abstract][Full Text] [Related]
10. The ins and outs of aquaporin-2 trafficking.
Brown D
Am J Physiol Renal Physiol; 2003 May; 284(5):F893-901. PubMed ID: 12676734
[TBL] [Abstract][Full Text] [Related]
11. Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP.
Wang M; Urenjak J; Fedele E; Obrenovitch TP
Biochem Pharmacol; 2004 Apr; 67(8):1619-27. PubMed ID: 15041479
[TBL] [Abstract][Full Text] [Related]
12. Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin.
Sun TX; Van Hoek A; Huang Y; Bouley R; McLaughlin M; Brown D
Am J Physiol Renal Physiol; 2002 Jun; 282(6):F998-1011. PubMed ID: 11997316
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of vasopressin signaling in collecting ducts from rats with CBL-induced liver cirrhosis.
Brønd L; Hadrup N; Salling N; Torp M; Graebe M; Christensen S; Nielsen S; Jonassen TE
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F806-15. PubMed ID: 15172884
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
[TBL] [Abstract][Full Text] [Related]
15. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
Takimoto E; Champion HC; Li M; Belardi D; Ren S; Rodriguez ER; Bedja D; Gabrielson KL; Wang Y; Kass DA
Nat Med; 2005 Feb; 11(2):214-22. PubMed ID: 15665834
[TBL] [Abstract][Full Text] [Related]
16. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.
Thiesson HC; Jensen BL; Jespersen B; Schaffalitzky de Muckadell OB; Bistrup C; Walter S; Ottosen PD; Veje A; Skøtt O
Am J Physiol Renal Physiol; 2005 May; 288(5):F1044-52. PubMed ID: 15613622
[TBL] [Abstract][Full Text] [Related]
18. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
Yuan Z; Hein TW; Rosa RH; Kuo L
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):720-5. PubMed ID: 18235020
[TBL] [Abstract][Full Text] [Related]
19. Vasopressin-induced membrane trafficking of TRPC3 and AQP2 channels in cells of the rat renal collecting duct.
Goel M; Sinkins WG; Zuo CD; Hopfer U; Schilling WP
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1476-88. PubMed ID: 17699554
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of renal vasopressin V2 receptor and aquaporin-2 expression parallels age-associated defects in urine concentration.
Tian Y; Serino R; Verbalis JG
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F797-805. PubMed ID: 15213068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
